E-LIB Suche - Ergebnisse für: Barthelemy, Philippe

1

Safety and efficacy of nivolumab in elderly patients with m..:

Mourey, Loïc ; Rainho, Larissa Tames ; Dalban, Cécile...
European Journal of Cancer. 201 (2024) - p. 113589 , 2024

Link: https://doi.org/10.1016/..

2

CaboCombo: a prospective, phase IV study of first-line cabo..:

Barthélémy, Philippe ; Dutailly, Pascale ; Qvick, Bryan..
Future Oncology. 20 (2024) 13 - p. 811-819 , 2024

Link: https://doi.org/10.2217/..

3

Validation of the Lung Immune Prognostic Index (LIPI) as a ..:

Carril-Ajuria, Lucia ; Lavaud, Pernelle ; Dalban, Cecile...
European Journal of Cancer. 204 (2024) - p. 114048 , 2024

Link: https://doi.org/10.1016/..

4

Adrenal Metastases Are Associated with Poor Outcomes in Pat..:

Billon, Emilien ; Dalban, Cécile ; Oudard, Stephane...
European Urology Oncology. 7 (2024) 4 - p. 742-750 , 2024

Link: https://doi.org/10.1016/..

5

Fluorinated GlycoNucleoLipid-based hydrogels as new spatiot..:

Gaubert, Alexandra ; Castagnet, Thibault ; Marsh, Jevon.
Drug Delivery and Translational Research. 14 (2024) 8 - p. 2079-2084 , 2024

Link: https://doi.org/10.1007/..

6

Perioperative dose-dense methotrexate, vinblastine, doxorub..:

Pfister, Christian ; Gravis, Gwenaelle ; Flechon, Aude...
The Lancet Oncology. 25 (2024) 2 - p. 255-264 , 2024

Link: https://doi.org/10.1016/..

7

Biomarqueurs émergents dans les cancers du rein à cellules ..:

Barthélémy, Philippe
Bulletin du Cancer. 111 (2024) 6 - p. 6S7-6S9 , 2024

Link: https://doi.org/10.1016/..

8

A Randomized, Open-label, Cross-over Phase 2 Trial of Darol..:

Colomba, Emeline ; Jonas, Sarah Flora ; Eymard, Jean-Christophe...
European Urology. 85 (2024) 3 - p. 274-282 , 2024

Link: https://doi.org/10.1016/..

9

A plain language summary of the TROPHY-U-01 study: sacituzu..:

Loriot, Yohann ; Kalebasty, Arash Rezazadeh ; Fléchon, Aude...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

10

Circulating Biomarkers Predictive of Treatment Response in ..:

Baboudjian, Michael ; Peyrottes, Arthur ; Dariane, Charles...
European Urology Oncology. , 2024

Link: https://doi.org/10.1016/..

11

Tailored immunotherapy approach with nivolumab with or with..:

Grimm, Marc-Oliver ; Esteban, Emilio ; Barthélémy, Philippe...
The Lancet Oncology. 24 (2023) 11 - p. 1252-1265 , 2023

Link: https://doi.org/10.1016/..

12

Gemcitabine plus platinum-based chemotherapy in combination..:

Thibault, Constance ; Fléchon, Aude ; Albiges, Laurence...
European Journal of Cancer. 186 (2023) - p. 83-90 , 2023

Link: https://doi.org/10.1016/..

13

Adjuvant nivolumab plus ipilimumab versus placebo for local..:

Motzer, Robert J ; Russo, Paul ; Grünwald, Viktor...
The Lancet. 401 (2023) 10379 - p. 821-832 , 2023

Link: https://doi.org/10.1016/..

14

Aptamer-based nanotrains and nanoflowers as quinine deliver..:

Cao, Mengyuan ; Vial, Anthony ; Minder, Laetitia...
International Journal of Pharmaceutics: X. 5 (2023) - p. 100172 , 2023

Link: https://doi.org/10.1016/..

15

Impact of First Line Antiangiogenic Therapy Duration on Niv..:

Guilhem-Ducléon, Guillemette ; Dalban, Cécile ; Negrier, Sylvie...
Clinical Genitourinary Cancer. 21 (2023) 6 - p. 643-652 , 2023

Link: https://doi.org/10.1016/..